Lisa Trivison Beck
Corporate Officer/Principal chez BRII BIOSCIENCES LIMITED
Profil
Lisa Trivison Beck is currently the Senior Vice President-Business Development at Brii Biosciences Ltd.
(China) since 2019.
Prior to this, she worked at Alexion Pharmaceuticals, Inc. as the Head-Transactions & Alliance Management from 2015 to 2018.
She also worked at GSK Plc for 24 years from 1991 to 2015, where she held the position of Director-Portfolio Management.
Ms. Beck completed her undergraduate degree from Vanderbilt University in 1984.
Postes actifs de Lisa Trivison Beck
| Sociétés | Poste | Début |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Corporate Officer/Principal | 17/12/2019 |
Anciens postes connus de Lisa Trivison Beck
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2018 |
| GSK PLC | Corporate Officer/Principal | 01/08/2015 |
Formation de Lisa Trivison Beck
| Vanderbilt University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
